Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS One. 2011 Mar 22;6(3):e17981. doi: 10.1371/journal.pone.0017981.
Peptide nucleic acid (PNA) is known to bind with extraordinarily high affinity and sequence-specificity to complementary nucleic acid sequences and can be used to suppress gene expression. However, effective delivery into cells is a major obstacle to the development of PNA for gene therapy applications. Here, we present a novel method for the in vitro delivery of antigene PNA to cells. By using a nucleocapsid protein derived from Simian virus 40, we have been able to package PNA into pseudovirions, facilitating the delivery of the packaged PNA into cells. We demonstrate that this system can be used effectively to suppress gene expression associated with multidrug resistance in cancer cells, as shown by RT-PCR, flow cytometry, Western blotting, and cell viability under chemotherapy. The combination of PNA with the SV40-based delivery system is a method for suppressing a gene of interest that could be broadly applied to numerous targets.
肽核酸(PNA)已知能够与互补核酸序列以极高的亲和力和序列特异性结合,并可用于抑制基因表达。然而,有效的细胞内递送是将 PNA 用于基因治疗应用的主要障碍。在这里,我们提出了一种将反义基因 PNA 递送到细胞的新方法。通过使用来自猴病毒 40 的核衣壳蛋白,我们能够将 PNA 包装成假病毒,从而促进包装的 PNA 进入细胞。我们证明,该系统可有效地抑制与癌细胞多药耐药相关的基因表达,如 RT-PCR、流式细胞术、Western 印迹和化疗下的细胞活力所示。PNA 与基于 SV40 的递送系统的结合是一种抑制感兴趣基因的方法,可广泛应用于众多靶标。